KIM GIBLIN: Open Payments
NPI 1215584032 · FORT LEE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$691 in 12 payments from 8 companies in 2025. Trend: 2023 $581 · 2024 $264 · 2025 $691
Food & beverage: $673Speaker / faculty: $18
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 1 | $143 |
| Penumbra, Inc. | 1 | $126 |
| Novo Nordisk Inc | 1 | $125 |
| Amgen Inc. | 1 | $100 |
| Bard Peripheral Vascular, Inc. | 1 | $77 |
| ABBVIE INC. | 3 | $53 |
| MDD US Operations, LLC | 3 | $52 |
| PFIZER INC. | 1 | $14 |
Products named: Korlym, Indigo System, Ozempic, EVENITY, Crosser IQ, Apokyn, UBRELVY, BOTOX.
Industry payments across NJ — which companies pay providers there.
